Tylor Walsh is a Senior Principal Process Engineer specializing in cell therapy at Genentech, having transitioned into this role in 2024 after serving as a Principal Process Engineer. With a robust background in bioprocess development, they have worked at various companies, including Lonza and CARBON ENGINEERING LIMITED, focusing on scalable processes for cGMP manufacturing of cell-based therapies. Tylor holds a PhD in Bioengineering and Biomedical Engineering from the University of Calgary, where they conducted research on Schwann cells for neurological treatments and contributed to multiple projects centered on computational fluid dynamics in bioreactors. Their work combines engineering principles with innovative approaches to optimize bioprocesses for clinical applications.
This person is not in the org chart
This person is not in any teams
This person is not in any offices